INSIGHTS ON DRUG DEVELOPMENT
-
Development Of A High Sensitivity SPE-LC-MS/MS Assay
Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.
-
Characterizing Binding Interactions By ITC
Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.
-
Embedded AI Is The Future Of Biopharmaceutical Recipe Creation
AI-assisted recipe creation works differently across MES and DCS environments. Where the AI sits in the automation architecture, embedded or added on, shapes how well it handles GMP-scale complexity.
-
Assessing Production And Stability Of Antibody Drug Conjugate Platforms
ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.
-
Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions11/20/2025
Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.
-
Long-Acting GnRH Antagonist For Advanced Prostate Cancer10/16/2026
Achieve rapid testosterone suppression for 6+ months with a novel low-volume subcutaneous depot formulation, eliminating the initial surge and offering a new approach for advanced prostate cancer treatment.
-
How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics9/2/2025
CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.
-
Color Consistency In UHMWPE Medical Textiles3/26/2026
Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.
-
How To Reduce Batch Loss In Biopharma Production12/12/2025
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
DRUG DEVELOPMENT SOLUTIONS
-
Ergonomic system microscope Leica DM1000 LED
The Leica DM1000 LED features long-life LED illumination that provides near daylight, bright illumination with constant color temperature and emits less heat.
The LED also eliminates the need for lamp changes, which saves time and money. Because of its low power consumption, the system is energy efficient. Users of the Leica DM1000 LED benefit from the system’s ability to uniquely adapt to every user.
It is ideal for all clinical laboratory applications, especially for cytology, haematology, and pathology. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
By streamlining the synthesis pathways, see how these products can effectively diminish the requisite number of developmental and manufacturing stages essential for generating payloads.
-
The BioAccord™ LC-MS System with dedicated workflows for the Sartorius Ambr® 15 and small bioreactors enables process engineers to directly measure Product Quality Attributes (PQAs) and cell culture media.
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.